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Abstract
Analyses of hypertensive confounding factors were identified by looking
retrospectively at patient demographics, medications, recent blood pressure and the
medical history of hypertensive patients with diabetes. The data trends found in this
database highlighted potential areas for improvement with regards to the care of patients
with this co-morbidity in the outpatient setting. All prescription anti-hypertensives
prescribed for the 102 patients followed the National Joint Committee (JNC-8)
Hypertension Guideline Algorithm. Of 102 adult males (over the age of 18), 22 patients
had a blood pressure that is out of control (over 140/90). Within this group of patients,
33.3% of the patients are overweight with a body mass index between 25.0 and 29.9.
Patients were obese 60.8% of the time with a BMI of 30.0 and above. Half of the patients
(51 of 102) have an active diagnosis of obstructive sleep apnea. There is a need for
continued aggressive treatment of hypertension in order to keep blood pressure below the
recommended 140/90mmHg per the JNC-8 Hypertension Guidelines for hypertensive
and diabetic patients. Several evidence-based practice recommendations were provided to
address the clinically significant findings mentioned above.
Keywords: Veteran, essential hypertension, diabetes mellitus, obesity
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Evaluation of Hypertensive Clinical Significance in a Primary Care Setting with Veterans
with Diabetes
Background & Significance
According to the Centers for Disease Control, National Vital Statistical Report,
there were 30,221 deaths from essential hypertension and hypertensive renal disease in
the United States in 2014. Nearly 75 million American adults have high blood pressure,
which is approximately one in every three adults. Of the 75 million adults with
hypertension, only about 54% have their hypertension in control. Early treatment of
hypertension is especially important in diabetic patients both to prevent cardiovascular
disease and to minimize the progression of renal disease and diabetic retinopathy (Gaede,
1999). There are many negative health outcomes associated with elevated blood pressure
including the risk for heart disease and stroke.
An estimated $48.6 billion dollars is spent yearly on hypertensive disease, which
includes the cost of health care services, medications to treat high blood pressure, and
missed days of work (Centers for Disease Control). Thus, aggressive treatment of
hypertension is not only the best thing for the wellbeing of patients, but it also has an
economic burden on our healthcare system and country.
Patients that are overweight or obese are at an increased risk of having
hypertensive disease. There is an overwhelming prevalence of both overweight and obese
patients in the United States. More than two-thirds of adults in the U.S are overweight or
obese according to the Centers for Disease Control. It is known that type-2 diabetes
mellitus and hypertension are associated with obesity. Thus, it is important to evaluate
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the blood pressure and confounding factors that are contributing to both hypertension and
diabetic discourse.
The Joint National Committee (JNC) published the “2014 Evidence Based
Guideline for the Management of High Blood Pressure in Adults”, which includes the
JNC – 8 Hypertension Guideline Algorithm for treatment of hypertension in various
subgroups. The guideline includes recommended lifestyle changes and pharmacotherapy
that is based on various co-morbid conditions. This guideline was used as a map for this
evidence based project. The current practices of the clinic were evaluated using the
guideline as an evidence based tool for best practice.
Evidence Based Practice Model
The beginning steps of the IOWA model were used to guide the planning of the
project. The IOWA model is presented in a flow chat format with many feedback loops to
ensure proper direction within a project. This helps to ensure that the user is meeting
certain criteria prior to moving too far into the project in order to help guarantee success
later on. The starting point of the IOWA model begins with a question concerning
clinical practice, either a problem focused trigger or a knowledge-focused trigger. With
regards to the evaluation of the hypertensive data set, the project trigger is a knowledgefocused trigger. There is not a direct “problem” that is causing the need for change, but
rather, the knowledge that best practice may not be currently adhered to, and we could do
better.
The IOWA model also has a question in the beginning of the model that asks whether
or not the project is an organizational priority. If the topic or problem is not of
importance to the institution, then the model recommends rethinking the project idea
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entirely. This topic was proposed by the overseeing physician and was expressed as a
priority. The IOWA model was fitting for planning this particular evidence based practice
project and will continue to serve as a beneficial guide for the organization moving
forward.
Project Plan Process
A Nurse Practitioner, Doctor of Philosophy student, accessed an electronic health
record at an outpatient Veterans Administration (VA) internal medicine clinic. From the
health record, a de-identified clinical database was assessed with hypertensive patient
demographics, medical history, family history and co-morbid diagnoses. The
demographics included in the database consisted of the following: age, sex, race, religion,
and military branch. Social behaviors such as tobacco use and alcohol use were also
included. Psychiatric medical history was included only if it was one of the following
conditions: major depressive disorder, generalized anxiety disorder, post traumatic stress
disorder. The following medical conditions were included, obstructive sleep apnea
(OSA), congestive heart failure (CHF), coronary artery disease (CAD), dyslipidemia,
chronic kidney disease (CKD), diabetes mellitus (DM), and a history of a transient
ischemic attack (TIA) or a cerebrovascular accident (CVA).
The database also included most recent lab values for hemoglobin A1C, HDL,
and body mass index (BMI). Antihypertensive medications including dosing prescribed
to the patient were included. There was a range from zero to four antihypertensive
medications prescribed. Baseline and most recent blood pressure readings were
incorporated and used to assess whether or not blood pressure was in control or not.
Finally, the database had family history within specific diagnoses that are most related to
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cardiac disease and cardiac risk factors. The following family history was included:
hypertension (HTN), cerebrovascular accident (CVA), myocardial infarction (MI),
coronary artery disease (CAD), and diabetes mellitus (DM). All of the patients in the
database had an ICD-10 billing code of hypertension. By creating data trends and looking
at the JNC-8 Guidelines, only certain factors were used in the analysis of confounding
factors to hypertension and diabetes.
There were 325 adult patients (over the age of 18) with a diagnosis of
hypertension within the provided database during the dates of August 1st, 2014 through
July 31st, 2016. Of the 325 patients, there were 108 patients with an active diagnosis
(ICD-10 code) of diabetes mellitus type II. The JNC-8 Hypertension Guideline Algorithm
begins by specifying that the tool is written for adults over the age of 18. It begins with
the recommendation that lifestyle modifications are implemented, a set blood pressure
goal is created and blood pressure lowering medications are started based on the
algorithm. The lifestyle changes are comprised of the following: smoking cessation,
blood glucose and lipid control, dietary changes and physical activity. Dietary changes
including healthy eating in which the Dietary Approaches to Stop Hypertension (DASH)
diet is recommended. Moderate alcohol consumption and a reduced sodium intake to no
more than 2,400 mg/day. The physical activity recommendations include moderate to
vigorous activity 3-4 days a week averaging 40 minutes per session.
Next, the JNC-8 Hypertension Guideline Algorithm differentiates between the
general population (no diabetes or CKD) and patients with diabetes or chronic kidney
disease (CKD). For the purposes of this project, the patients with the co-morbidity of
diabetes were selected. It is critical to prevent chronic kidney disease or renal failure in

11

this population. Patients with both hypertensive disease and diabetes are at a significant
risk of poor health outcomes.
Male patients were included in the analysis. There were a total of 102 adult male,
veteran patients with an active diagnosis of both hypertension and diabetes type II.
Within the diabetic/hypertensive co-morbid diagnosis on the algorithm, the blood
pressure goal is goal less than 140/90. Of note, patients age 60 and above without
diabetes or chronic kidney disease have a more liberal blood pressure goal of less than
150/90. This does not apply for geriatric patients over 60 with diabetes due to the
increased cardiovascular risk with this comorbidity. Thus, all patients at any age with
both hypertension and diabetes have a blood pressure goal of 140/90 or below.
According to the guideline, patients are then divided into either black or nonblack. This category will help to determine the pharmacotherapy recommendations for
the patient. From this point, each of the patients within this co-morbid group, were
divided into patients that were either black or non-black per the guideline. There were 83
nonblack patients and nineteen black patients with hypertension and diabetes. The most
recent blood pressure was then analyzed to see if the blood pressure is in control
(<140/90) or out of control (>140/90). Of the 83 non-black patients, twenty-one of the
patients had a blood pressure that is considered out of range and of the black patients,
there was one patient with a blood pressure out of control. The pharmacotherapy that was
prescribed to each of the patients with a blood pressure that is out of range was analyzed
to ensure that it is following the JNC-8 Hypertension Guideline Algorithm.
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Evaluation & Results
Outcomes
This next section discusses the evidence based practice project outcomes. Blood pressure
control, the antihypertensives prescribed to the patient, body mass index, obstructive
sleep apnea, and other contributing factors are discussed herein.
Blood Pressure Control. Out of 102 adult males with a diagnosis of diabetes
mellitus type 2 and hypertension, twenty-two patients had a blood pressure that is out of
control (over 140/90). All prescription antihypertensives followed the National Joint
Committee (JNC) Hypertension Guideline Algorithm.
Anti-Hypertensive’s Prescribed. All prescription antihypertensives followed the
National Joint Committee (JNC) Hypertension Guideline Algorithm. The medications are
specific to patients with both hypertension and diabetes. Also, the medication
recommendations differ between black and non-black patients. Of the 102 adult males,
twenty-two patients had a blood pressure of 140/90 or above. One of the twenty-two
patients is a black male, and the other twenty-one patients are considered non-black.
The one black patient with an elevated blood pressure is on two anti-hypertensive
medications. The medications prescribed were hydroclorothiazide (HCTZ) 25 mg per day
and verapamil 240mg daily. Both medications are according to the JNC guidelines. The
twenty-one non-black patients with elevated blood pressure were on varying medication
regimens but all pharmacologic therapy was prescribed according to recommendations.
Two of the patients were on no medications. Eight of the patients were on single therapy.
Four of the patients are on double therapy. Six of the patients are on triple therapy. And,
finally, one patient was on quadruple therapy.
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Out of the eight patients on single therapy, six of the patients were prescribed
lisinopril, which is an angiotensin-converting-enzyme inhibitor (ace-inhibitor). The
dosing ranged from 5mg to 40mg per day. One patient was prescribed metoprolol 50mg
per day, which is a beta-blocker. The last patient was prescribed a calcium channel
blocker (CCB), amlodipine 10mg daily. The recommended therapy in diabetic
hypertensive patients is an ace-inhibitor or an angiotensin II receptor blocker (ARB),
calcium channel blocker (CCB) or diuretic.
There were four of the twenty-one patients prescribed dual therapy. Patient one
was on atenolol 50 mg per day and losartan 100mg per day. Patient two was on
metoprolol 100mg per day and lisinopril 10mg per day. Patient three was on HCTZ 25mg
daily and losartan 100mg daily. The forth patient was on HCTZ 25mg per day and
lisinopril 40mg per day.
Five of the twenty-one patients were prescribed triple therapy. Patient one and
two were on the same three medications, although doses varied. The two patients were
both on amlodipine (10mg daily), atenolol (25mg and 100mg daily), and lisinopril (40mg
every day). The other two patients were prescribed different medication combinations.
Patient three was prescribed amlodipine 4mg daily, atenolol 100mg daily and losartan
100mg per day. Patient four was prescribed spironolactone 25 mg, furosemide 80mg and
metoprolol 50mg per day. Finally, patient five was on HCTZ 25mg/triamterene 37.5mg,
atenolol 50mg daily and lisinopril 40mg a day.
Finally, two of the twenty-one patients were prescribed quadruple therapy. Patient
one was prescribed an ace-inhibitor, beta-blocker, diuretic and centrally-acting agent. The
specific medications that patient one was prescribed include the following: lisinopril

14

40mg per day, atenolol 100mg daily, HCTZ 25mg per day, and clonidine 0.1 mg daily.
This combination of medications follows the JNC-8 Guidelines. Patient two was
prescribed HCTZ 20mg/lisinopril 20mg, furosemide 20mg daily, and metoprolol 100mg
per day. See table 1.
Body Mass Index. Of the 102 patients, 33.3% of the patients are overweight with
a body mass index between 25.0 and 29.9. And, 60.8% of these patients were obese with
a BMI of 30.0 and above. Therefore, approximately 94% of these patients are suffering
from being either overweight or obese. Only 5.9% of the patients were considered to have
a healthy weight. See figure 1. With regards to the twenty-two patients with a blood
pressure above 140/90, only two out of the twenty-two (9.1%) patients are at a healthy
weight (BMI 18.5 to 24.9). Therefore, eight out of the twenty-two (36.4%) patients are
overweight (BMI 25 to 29.9). Finally, twelve out of the twenty-two (54.5%) patients are
obese (BMI 30 and above). Together, 91% of the patients with elevated blood pressure
are either overweight or obese.
Obstructive Sleep Apnea. Half (50%) of the patients (51 of out 102) have an
active diagnosis of obstructive sleep apnea (OSA). See figure 2. This data is based of an
active ICD-10 code within the patient’s medical record. The group of patients with
elevated blood pressure, over 140/90, 59% (13/22) had an active diagnosis of obstructive
sleep apnea. Therefore, 41% (9/22) of the patients with an elevated blood pressure do not
have an active diagnosis of obstructive sleep apnea. These patients are not currently being
screened for OSA and therefore, there is an opportunity to screen this patient population.
If these patients have OSA, but are not being treated for the disease, it may be
contributing to their high blood pressure and even making it more difficult to decrease. A
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prospective cohort study of 1889 participants was conducted by Marin, et al. (2013) and
found that “compared with participants without OSA, the presence of OSA was
associated with increased adjusted risk of incident hypertension; however, treatment with
CPAP therapy was associated with a lower risk of hypertension.” In order to compare the
prevalence of obstructive sleep apnea in patients with both hypertension and diabetes, an
analysis of the number of patients with OSA with hypertension without diabetes was
performed. There were 180 patients within the cohort with an active diagnosis of
hypertension without diabetes. Of the 180 patients, 75 (41.7%) patients have an active
diagnosis of OSA. Consequently, there was a lower incidence of OSA in patients with
hypertension and no diabetes.
Other Contributing Factors. After analyzing various other risk factors that
could be contributing to the hypertensive and diabetic patient’s cardiovascular health,
there were a significant number of patients with an active diagnosis of dyslipidemia. Out
of the 102 patients, 85.2% (87) have an active diagnosis of dyslipidemia. Of those
patients, seventeen of them have blood pressure that is out of range (17/22 patients) or
77.3% of the out of control patients also have dyslipidemia, contributing to their overall
cardiovascular risk. 16.7% (17/102) have an active diagnosis of coronary artery disease
(CAD), and two of the seventeen patients have blood pressure out of range. With regards
to congestive heart failure (CHF), 4.9% (5/102) of the patients have an active diagnosis
of CHF, and all (100%) are in hypertensive control.
Evidence Based Practice Suggestions
It is imperative to aggressively treat hypertensive patients to obtain hypertensive
control, especially in the setting of type-2 diabetes mellitus. According to the JNC-8
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Guidelines, patients with an elevated blood pressure, initial presentation and subsequent
readings, lifestyle modifications should be reinforced to the patient. “For all persons with
hypertension, the potential benefits of a healthy diet, weight control, and regular exercise
cannot be overemphasized” (James, et. al, 2014). There are an overwhelming number of
patients that are either overweight of obese with the co-morbidity of hypertension and
type-2 diabetes mellitus in this group of veteran patients. According to the JNC-8
Guidelines, weight reduction is a priority for hypertensive patients. Specifically, the
guideline suggests the DASH diet for hypertensive/diabetic patients. The DASH diet is
endorsed by The National Heart, Lung and Blood Institute, the American heart
Association (AHA) and the Mayo Clinic. The DASH diet has been proven to decrease
systolic and diastolic blood pressure. This is largely due to the diets sodium restriction.
Therefore, all of the patients with these ICD-10 codes will be referred for nutritional
counseling to obtain education on the DASH diet. The providers at this outpatient clinic
were educated on the DASH diet and low-sodium diet (may be done through dietician).
Weight management/ reduction in body mass index will be discussed with the patients in
this clinic, especially for patients with an elevated blood pressure. Brown et. al (1989)
completed a meta-analysis of 89 studies that assessed educational interventions and
outcomes specific to weight loss in diabetes care. The studies included demonstrated
support for diabetes education in primary care, specifically; nutritional therapy
counseling had the largest statistically significant impact on both weight loss and
metabolic control. While, this meta-analysis focused on the diabetic population, the
patients included in this analysis had both diabetes and hypertension. Control of both
diseases can be assisted by weight reduction.
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There is evidence to support group weight loss programs. While, these programs
may be costly to run, the benefits may outweigh the risks with regards to long-term
complications. Rock et. al (2014) performed a randomized controlled trial with 227
overweight of obese with type-2 diabetes. The participants in the weight loss program,
which included in person diet and exercise counseling, lost 7.8% of their initial weight as
compared to 2.1% in the control group. The study found that a structured weight loss
program resulted in greater weight loss and improved glycemic control in type-2
diabetes, improving cardiovascular risk factors.
There is research that demonstrates the increased risk of high blood pressure in
patients with obstructive sleep apnea. In a prospective cohort study with 5,382 patients
referred to sleep study, 922 of the patients initiated continuous positive airway pressure
(CPAP) therapy. It was found that the presence of OSA was associated with an increased
risk of incident hypertension (Marin, et. al, 2012). Also, there is evidence to support that
it is more difficult to lower blood pressure if patients are suffering from OSA. In a
randomized placebo controlled cross over study, the effects of four weeks of CPAP on 68
patients with hypertension were studied. The patients were not receiving hypotensive
medications. Blood pressure was reduced by greater amounts in patients with
intermittent nocturnal hypoxemia with the use of CPAP and systolic blood pressure was
decreased by 4.0mm Hg and diastolic blood pressure by 5.0mm Hg. For this reason, this
clinic will begin screening all patients with co-morbid diagnosis for obstructive sleep
apnea. Any patients with hypertension and possible sleep apnea will be referred for sleep
study and CPAP, if indicated.
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Sleep apnea is more prevalent in patients with type-2 diabetes than patients
without diabetes. Einhorn et al. (2007) completed a study with 279 adults with type- 2
diabetes. They found that there was a high prevalence of OSA in the diabetic patient
population. They found that sleep apnea was associated with males, ages 62 and older,
with a body mass index greater than or equal to 30kg/m2, snoring and reports of stopping
breathing during sleep. Storgarrd et al. (2014) also found that approximately one third of
patients with type-2 diabetes also had a co-morbidity of obstructive sleep apnea with a
cross-sectional study including 200 participates. Therefore, it is even more important that
patients with both hypertension and diabetes are screened for obstructive sleep apnea on a
regular basis. Within the cohort of veterans in this study, patients with a diagnosis of
hypertension without diabetes or chronic kidney disease, had a diagnosis of obstructive
sleep apnea 41.7% of the time, compared to a prevalence of 50% of the patients with
hypertensive patients with diabetes. This cohort of patients is reflective of the studies and
research previously mentioned above.

Implications for clinical practice
Several future Doctor of Nursing Practice (DNP) students will implement the
clinically significant outcomes and recommendations identified from this research. One
student will begin screening patients with this co-morbidity for obstructive sleep apnea
using either the STOP-Bang Screening tool or the Epworth Sleepiness Scale (ESS). This
will help to identify patients that are suffering from OSA but have not been diagnosed
and treated. Also, due to the large percentage of both overweight and obese patients in
this data set, a student will implement the recommended interventions to reduce body
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mass index (BMI). The identified areas of concern, increased BMI and high prevalence
of OSA will be addressed by these students and hopefully will then decrease blood
pressure in these patients. Clinically, there is still a need for further intervention in this
population, as there is work to do in order to meet blood pressure goal standards. With
regards to future research, it would be interesting to look at the relationship between
patients with both hypertension and diabetes and other psychosocial contributing factors
such as anxiety, depression and post-traumatic stress disorder (PTSD). Also, it would be
helpful to have a better understanding of how often patients actually use their CPAP
machines and any interventions that may increase compliance.
There are many areas within this patient population in which further education
could be beneficial. This could be evaluated with a pre and posttest to gain a better idea
of how much these patients understand the diseases and the consequences of poor blood
pressure control over time. There is an opportunity formation of new statewide or
national policy that encourages lifestyle changes among these patients through the use of
incentives. Due to the complications associated with uncontrolled hypertension,
especially in the setting of diabetes, there can be financial savings long term if blood
pressure is controlled.

Conclusions
There is a need for continued aggressive treatment of hypertension to maintain
blood pressure at or below the recommended 140/90mmHg per the JNC-8 Hypertension
Guidelines for hypertensive and diabetic patients. All patients with a co-morbidity of
hypertension and diabetes should be referred for nutritional counseling. Also, the Dietary
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Approach to Stop Hypertension (DASH) diet should be recommended to these patients.
Weight management should be discussed with these patients. Finally, patients with
hypertension and diabetes should be screened for obstructive sleep apnea.
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Table 1. Twenty-One Non-Black Patients w/ Out of Control Blood Pressure

Figure 1. Body Mass Index of 102 Hypertensive & Diabetic Patients

Underweight
Normal
Overweight
Obese
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Figure 2. Hypertensive and Diabetic Patients with or without Obstructive Sleep Apnea

Figure 3. Picture Aid of Clinical Significance
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